BUSINESSJun 8 · 06:10 UTCBLOOMBERGJillian Deutsch

Tate & Lyle Latest Loss for London After Sale to US Rival

Tate & Lyle, which focuses on sugar replacements and calorie reducers, was sold to a US rival, marking a loss for London. The company is also expanding into dietary fibers.

Nexus surfaces and summarizes. The full story lives at the source.

Mentioned

Tate & LyleorganizationUS RivalorganizationLondonplacesugar replacementstopiccalorie reducerstopicdietary fiberstopic

Spot something wrong with this article?Report a problem →

Forward this

Related Signal

Adjacent reporting

BUSINESSJun 8 · 07:30 UTC
Britain for sale: Ingredients firm Tate & Lyle is snapped up by US rival in £2.7billion deal
BUSINESSMay 12 · 12:02 UTC
Hims & Hers plummets 15% after first-quarter loss, weak earnings guidance
BUSINESSJun 8 · 06:41 UTC
Tate & Lyle agrees to £2.7bn takeover from US rival Ingredion
BUSINESSMay 11 · 20:28 UTC
Hims Sales Miss on Rising Competition for Weight-Loss Drugs
BUSINESSJun 7 · 16:01 UTC
Ingredion Is in Advanced Talks to Acquire Tate & Lyle for £2.7 billion
BUSINESSApr 14 · 15:02 UTC
Novo Nordisk partners with OpenAI in weight loss drug race